SOLID TUMORS
Clinical trials for SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS trials appear
Sign up with your email to follow new studies for SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Terminated trial tests Triple-Threat attack on tough cancers
Disease control TerminatedThis study tested whether combining three different cancer drugs was safe and could help control advanced solid tumors that had stopped responding to other treatments. It involved 70 people with cancers like advanced lung cancer and colorectal cancer. The goal was to see if this …
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested the safety and highest tolerable dose of an experimental drug called INCB062079 in people with advanced liver cancer and other solid tumors. The trial enrolled 25 participants whose cancers had progressed after standard treatments and was designed to…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test of Pfizer's new cancer drug begins
Disease control TerminatedThis early-stage study tested the safety and determined the right dosage of a new drug called PF-08046031 for adults with advanced melanoma and other solid tumors that have spread and have no other approved treatment options. The main goal was to identify side effects and see how…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First test of new cancer drug halted early
Disease control TerminatedThis was an early safety study for a new cancer drug called ABBV-303, tested alone and in combination with another drug, budigalimab. It involved adults with advanced solid tumors that had stopped responding to other treatments. The main goal was to find a safe dose and see how t…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early cancer drug trial halted after safety testing
Disease control TerminatedThis early-stage study tested the safety of a new drug called LY3127804, both alone and combined with an existing cancer drug (ramucirumab), in 62 people with advanced solid tumors. The main goal was to find safe dosage levels and understand how the body processes these drugs. Th…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug tested for safety in advanced cases
Disease control TerminatedThis early-phase study aimed to find a safe dose and check the side effects of a new drug called INCB057643 for people with advanced cancers that had stopped responding to other treatments. It tested the drug alone and combined with standard treatments in about 137 participants w…
Matched conditions: SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Early cancer drug trial halted after testing in just 3 patients
Disease control TerminatedThis was an early-stage study to check the safety and find a safe dose of an experimental oral drug called INCB086550 for Japanese patients with advanced solid tumors that had stopped responding to standard treatments. The study was terminated early and only enrolled three partic…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Scientists track cancer Drug's journey through the body
Knowledge-focused TerminatedThis early-stage study aimed to understand how the body absorbs, breaks down, and eliminates an experimental cancer drug called subasumstat in adults with advanced solid tumors. Participants received a single dose containing a tiny, safe amount of radioactive tracer to track the …
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC